Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

twiist Loop Algorithm

K-Number: K262576 · 2026-10-15

ApplicantDeka Research and Development Corp.
Decision Date2026-10-15
Product CodeQJI
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

twiist Loop Algorithm is the device name listed in this FDA 510(k) record. The listed applicant is Deka Research and Development Corp.. It received FDA 510(k) clearance on 2026-10-15 under 510(k) number K262576. The device is classified under product code QJI. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the twiist Loop Algorithm?

twiist Loop Algorithm is a medical device that received FDA 510(k) clearance on 2026-10-15. The listed applicant is Deka Research and Development Corp.. The 510(k) number is K262576.

When did twiist Loop Algorithm receive FDA 510(k) clearance?

twiist Loop Algorithm received FDA 510(k) clearance on 2026-10-15, under 510(k) number K262576.

Who is the listed applicant for twiist Loop Algorithm?

The FDA 510(k) record lists Deka Research and Development Corp. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for twiist Loop Algorithm?

The FDA product code for twiist Loop Algorithm is QJI.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT04745156A Study Using Brain Stimulation and Behavioral Therapy to Increase Extent of Resection in Low-Grade GliomasNOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED

Other records listing Deka Research and Development Corp. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K250930twiist systemK250357RemunityPRO™ Pump for Remodulin® (treprostinil) InjectionK241736Remunity 2.0 Pump for Remodulin (treprostinil) InjectionK243354Remunity SystemK172601Next Generation iBOTK124018AMIA AUTOMATED PD SYSTEM

View all 12 devices →

Related Devices (Code: QJI)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K261896iOS CamAPS FXCamDiabK262763iLet Dosing Decision SoftwareBeta Bionics, Inc.K261962SmartGuard Technology; Predictive Low Glucose TechnologyMedtronic MiniMedK261461Omnipod 6 algorithmInsulet CorporationK260429Control-IQ+ technologyTandem Diabetes Care, Inc.K253701SmartGuard Technology; Predictive Low Glucose TechnologyMedtronic Minimed

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑